Top

Quality of Life Research

Gepubliceerd in:

01-07-2015

The Patient Activation Measure: a validation study in a neurological population

Auteurs: Tanya L. Packer, George Kephart, Setareh Ghahari, Åsa Audulv, Joan Versnel, Grace Warner

Gepubliceerd in: Quality of Life Research | Uitgave 7/2015

Abstract

Purpose

To assess the validity of the Patient Activation Measure (PAM13) of patient activation in persons with neurological conditions.

Methods

“The Everyday Experience of Living with and Managing a Neurological Condition” (The LINC study) surveyed 948 adults with neurological conditions residing in Canada in 2011 and 2012. Using data for 722 respondents who met coding requirements for the PAM-13, we examined the properties of the measure using principle components analysis, inter-item correlations and Cronbach’s alpha to assess unidimensionality and internal consistency. Rasch modeling was used to assess item performance and scaling. Construct validity was assessed by calculating associations between the PAM and known correlates.

Results

PAM-13 provides a suitably reliable and valid instrument for research in patients with neurological conditions, but scaling problems may yield measurement error and biases for those with low levels of activation. This is of particular importance when used in clinical settings or for individual client care. Our study also suggests that measurement of activation may benefit from tailoring items and scaling to specific diagnostic groups such as people with neurological conditions, thus allowing the PAM-13 to recognize unique attributes and management challenges in those conditions.

Conclusions

The PAM-13 is an internally reliable and valid tool for research purposes. The use of categorical activation “level” in clinical settings should be done with caution.

vorige artikel Content validity and legacy patient-reported outcome measures in cancer

volgende artikel Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation

Hibbard, J. H., & Greene, J. (2013). What the evidence shows about patient activation: Better health outcomes and care experiences; fewer data on costs. Health Affairs (Millwood), 32(2), 207–214.CrossRef

Wagner, E. H. (1998). Chronic disease management: What will it take to improve care for chronic illness? Effective clinical practice, 1(1), 2–4.PubMed

Wagner, E. E. H. (2001). Meeting the needs of chronically ill people. British Medical Journal, 323(7319), 945–946.PubMedCentralPubMedCrossRef

Barr, V. J., Robinson, S., Marin-Link, B., Underhill, L., Dotts, A., Ravensdale, D., et al. (2003). The expanded chronic care model: An integration of concepts and strategies from population health promotion and the chronic care model. Hospital Quarterly, 7(1), 73–82.PubMed

Greene, J., & Hibbard, J. H. (2012). Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. Journal of General Internal Medicine, 27(5), 520–526.PubMedCentralPubMedCrossRef

Stepleman, L., Rutter, M., Hibbard, J., Johns, L., Wright, D., & Hughes, M. (2010). Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. Disability and Rehabilitation, 32(19), 1558–1567.PubMedCrossRef

Fowles, J. B., Terry, P., Xi, M., Hibbard, J., Bloom, C. T., & Harvey, L. (2009). Measuring self-management of patients’ and employees’ health: Further validation of the patient activation measure (PAM) based on its relation to employee characteristics. Patient Education and Counseling, 77(1), 116–122.PubMedCrossRef

Hibbard, J. H., Collins, P. A., Mahoney, E., & Baker, L. H. (2010). The development and testing of a measure assessing clinician beliefs about patient self-management. Health Expectations, 13(1), 65–72.PubMedCrossRef

Hibbard, J. H., Mahoney, E. R., Stockard, J., & Tusler, M. (2005). Development and testing of a short form of the patient activation measure. Health Services Research, 40(6 Pt 1), 1918–1930.PubMedCentralPubMedCrossRef

10.

Hibbard, J. H., Mahoney, E. R., Stock, R., & Tusler, M. (2007). Do increases in patient activation result in improved self-management behaviors? Health Services Research, 42(4), 1443–1463.PubMedCentralPubMedCrossRef

11.

Kaplan, R. M., Anderson, J. P., Wu, A. W., Mathews, W. C., Kozin, F., & Orenstein, D. (1989). The quality of well-being scale. Applications in AIDS, cystic fibrosis, and arthritis. Medical Care, 27(3 Suppl.), 27–43.CrossRef

12.

Alexander, J. A., Hearld, L. R., Mittler, J. N., & Harvey, J. (2012). Patient–physician role relationships and patient activation among individuals with chronic illness. Health Services Research, 47(3 Pt 1), 1201–1223.PubMedCentralPubMedCrossRef

13.

Glasgow, R. E., Toobert, D. J., Hampson, S. E., & Strycker, L. A. (2002). Implementation, generalization and long-term results of the “choosing well” diabetes self-management intervention. Patient Education Counseling, 48(2), 115–122.PubMedCrossRef

14.

Begum, N., Donald, M., Ozolins, I. Z., & Dower, J. (2011). Hospital admissions, emergency department utilisation and patient activation for self-management among people with diabetes. Diabetes Research and Clinical Practice, 93(2), 260–267.PubMedCrossRef

15.

Hibbard, J. H., & Cunningham, P. J. (2008). How engaged are consumers in their health and health care, and why does it matter? Res Briefs, 8, 1–9.

16.

Hibbard, J. H., Stockard, J., Mahoney, E. R., & Tusler, M. (2004). Development of the patient activation measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Services Research, 39(4 Pt 1), 1005–1026.PubMedCentralPubMedCrossRef

17.

Insignia Health. (2011). Patient activation measure (PAM) 13™ License Materials copyright Insignia Health, LLC.

18.

Brenk-Franz, K., Hibbard, J. H., Herrmann, W. J., Freund, T., Szecsenyi, J., Djalali, S., et al. (2013). Validation of the German version of the patient activation measure 13 (PAM13-D) in an international multicentre study of primary care patients. PLoS One, 8(9), e74786.PubMedCentralPubMedCrossRef

19.

Zill, J. M., Dwinger, S., Kriston, L., Rohenkohl, A., Harter, M., & Dirmaier, J. (2013). Psychometric evaluation of the German version of the patient activation measure (PAM13). BMC Public Health, 13, 1027-2458-13-1027.CrossRef

20.

Maindal, H. T., Sandbaek, A., Kirkevold, M., & Lauritzen, T. (2011). Effect on motivation, perceived competence, and activation after participation in the “Ready to Act” programme for people with screen-detected dysglycaemia: A 1-year randomised controlled trial, Addition-DK. Scandinavian Journal of Public Health, 39(3), 262–271.PubMedCrossRef

21.

Rademakers, J., Nijman, J., van der Hoek, L., Heijmans, M., & Rijken, M. (2012). Measuring patient activation in The Netherlands: Translation and validation of the American short form patient activation measure (PAM13). BMC Public Health, 12, 577.PubMedCentralPubMedCrossRef

22.

Green, C. A., Perrin, N. A., Polen, M. R., Leo, M. C., Hibbard, J. H., & Tusler, M. (2010). Development of the patient activation measure for mental health. Administration and Policy in Mental Health, 37(4), 327–333.PubMedCentralPubMedCrossRef

23.

Skolasky, R. L., MacKenzie, E. J., Riley, L. H, I. I. I., & Wegener, S. T. (2009). Psychometric properties of the patient activation measure among individuals presenting for elective lumbar spine surgery. Quality of Life Research, 18(10), 1357–1366.PubMedCentralPubMedCrossRef

24.

Skolasky, R. L., Green, A. F., Scharfstein, D., Boult, C., Reider, L., & Wegener, S. T. (2011). Psychometric properties of the patient activation measure among multimorbid older adults. Health Services Research, 46(2), 457–478.PubMedCentralPubMedCrossRef

25.

Hung, M., Carter, M., Hayden, C., Dzierzon, R., Morales, J., Snow, L., et al. (2013). Psychometric assessment of the patient activation measure short form (PAM-13) in rural settings. Quality of Life Research, 22(3), 521–529.PubMedCrossRef

26.

Cook, D. A., & Beckman, T. J. (2006). Current concepts in validity and reliability for psychometric instruments: Theory and application. The American Journal of Medicine, 119(2), 166.e7-166.16.CrossRef

27.

Malcomson, K. S., Lowe-strong, A. S., & Dunwoody, L. (2008). What can we learn from the personal insights of individuals living and coping with multiple sclerosis? Disability and Rehabilitation, 30(9), 662–674.PubMedCrossRef

28.

Versnel, J., Packer, T., Weeks, L. E., Brown, J., Godwin, M., Hutchinson, S., et al. (2013). The everyday experience of living with and managing a neurological condition (the LINC study): Study design. BMC Neurology, 13, 30-2377-13-30.CrossRef

29.

Caesar-Chavannes, C. R., & MacDonald, S. (2013). Cross-Canada forum—National Population Health Study of neurological conditions in Canada. Chronic Diseases Injuries in Canada, 33(3), 188–191.PubMed

30.

Statistics Canada. (2009). User guide 2007–2008 microdata files. Canadian Community Health Survey (CCHS)—Annual Component. Ottawa: Statistics Canada.

31.

Harvey, L., Fowles, J. B., Xi, M., & Terry, P. (2012). When activation changes, what else changes? The relationship between change in patient activation measure (PAM) and employees’ health status and health behaviors. Patient Education and Counseling, 88(2), 338–343.PubMedCrossRef

32.

Hawthorne, G., Osborne, R. H., Taylor, A., & Sansoni, J. (2007). The SF36 version 2: Critical analyses of population weights, scoring algorithms and population norms. Quality of Life Research, 16(4), 661–673.PubMedCrossRef

33.

Guilfoyle, M. R., Seeley, H. M., Corteen, E., Harkin, C., Richards, H., Menon, D. K., et al. (2010). Assessing quality of life after traumatic brain injury: Examination of the short form 36 health survey. Journal of Neurotrauma, 27(12), 2173–2181.PubMedCrossRef

34.

Jenkinson, C., Hobart, J., Chandola, T., Fitzpatrick, R., Peto, V., Swash, M., et al. (2002). Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: Tests of data quality, score reliability, response rate and scaling assumptions. Journal of Neurology, 249(2), 178–183.PubMedCrossRef

35.

Marra, C. A., Woolcott, J. C., Kopec, J. A., Shojania, K., Offer, R., Brazier, J. E., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine, 60(7), 1571–1582.PubMedCrossRef

36.

Feng, Y., Bernier, J., McIntosh, C., & Orpana, H. (2009). Validation of disability categories derived from Health Utilities Index Mark 3 scores. Health Reports, 20(2), 43–50.PubMed

37.

Godwin, M., Streight, S., Dyachuk, E., van den Hooven, E. C., Ploemacher, J., Seguin, R., et al. (2008). Testing the Simple Lifestyle Indicator Questionnaire: Initial psychometric study. Canadian Family Physician, 54(1), 76–77.PubMedCentralPubMed

38.

R Development Core Team. (2006). R: A language and environment for statistical computing. Vienna: R Development Core Team.

39.

Mair, P., & Hatzinger, R. (2006). eRm; extended Rasch models. R package version 0.3.2. http://CRAN.R-project.org/. (Accessed October 2013).

40.

Mair, P., & Hatzinger, R. (2007). CML based estimation of extended Rasch models with the eRm package in R. Psychology Science, 49(1), 26–43.

41.

Hattie, J. (1985). Methodology review: Assessing unidimensionality of tests and items. Applied Psychological Measurement, 9(2), 139–164.CrossRef

42.

Maindal, H. T., Sokolowski, I., & Vedsted, P. (2009). Translation, adaptation and validation of the American short form patient activation measure (PAM13) in a Danish version. BMC Public Health, 9, 209.PubMedCentralPubMedCrossRef

43.

World Health Organization. (2003). Adherence to long-term therapies: Evidence for action (p. 12). Geneva: World Health Organization.

44.

Remington, G., Rodriguez, Y., Logan, D., Williamson, C., & Treadaway, K. (2013). Facilitating medication adherence in patients with multiple sclerosis. International Journal of MS Care, 15(1), 36–45.PubMedCentralPubMedCrossRef

45.

Grosset, D., Antonini, A., Canesi, M., Pezzoli, G., Lees, A., Shaw, K., et al. (2009). Adherence to antiparkinson medication in a multicenter European study. Movement Disorders, 24(6), 826–832.PubMedCrossRef

46.

Drennan, J. (2003). Cognitive interviewing: Verbal data in the design and pretesting of questionnaires. Journal of Advanced Nursing, 42(1), 57–63.PubMedCrossRef

47.

Ghahari, S., Forwell, S., & Khoshbin, L. (2014). The multiple sclerosis self-management scale: Clinicometric testing. International Journal of MS Care,. doi:10.7224/1537-2073.2013-019.PubMedCentralPubMed

48.

49.

Mosen, D. M., Schmittdiel, J., Hibbard, J., Sobel, D., Remmers, C., & Bellows, J. (2007). Is patient activation associated with outcomes of care for adults with chronic conditions? Journal of Ambulatory Care Management, 30(1), 21–29.PubMedCrossRef

50.

Ledford, C. J. W., Ledford, C. C., & Childress, M. A. (2013). Exploring patient activation in the clinic: Measurement from three perspectives. Health Education and Behavior, 40(3), 339–345.PubMedCrossRef

Titel: The Patient Activation Measure: a validation study in a neurological population
Auteurs: Tanya L. Packer
George Kephart
Setareh Ghahari
Åsa Audulv
Joan Versnel
Grace Warner
Publicatiedatum: 01-07-2015
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 7/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-014-0908-0

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2015

Diabetes quality of life perception in a multiethnic population

Reliability and validity of the Dutch-translated Body Image Scale

Relationship between socioeconomic status and quality of life in older adults: a path analysis

Quality of life and comorbidity among older home care clients: role of positive attitudes toward aging

The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials

Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation